There are a couple of pieces to that important question.
First, as we know, there have been a number of different studies on our reaction to and our collaboration in terms of COVID-19, including several reports from the Auditor General and significant internal collaborative studies within the federal government and between the federal government and other governments. Those have also involved, obviously, public health agencies. I personally have had many meetings with stakeholders and experts from different communities, and I have invited them to keep providing us with their input on that reaction.
We are currently discussing a bill in the House that is also pointing to the importance of having a review of COVID-19.
Finally, we need to do this in two ways. First, it has to be inclusive of all perspectives, and second, it has to be inclusive of all aspects of that work.